• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当代前瞻性队列中用于预测心血管风险的合并队列方程的评估

Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort.

作者信息

Emdin Connor A, Khera Amit V, Natarajan Pradeep, Klarin Derek, Baber Usman, Mehran Roxana, Rader Daniel J, Fuster Valentin, Kathiresan Sekar

机构信息

Center for Human Genetic Research and Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.

Center for Human Genetic Research and Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts.

出版信息

Am J Cardiol. 2017 Mar 15;119(6):881-885. doi: 10.1016/j.amjcard.2016.11.042. Epub 2016 Dec 18.

DOI:10.1016/j.amjcard.2016.11.042
PMID:28061997
Abstract

Most guidelines suggest a baseline risk assessment to guide atherosclerotic cardiovascular disease (ASCVD) prevention strategies. The American Heart Association/American College of Cardiology Pooled Cohort Equations (PCEs) is one tool to assess baseline risk; however, the accuracy of this tool has been called into question. We aimed to examine the calibration and discrimination of the PCEs in the BioImage study, a contemporary multiethnic cohort of asymptomatic adults enrolled from 2008 to 2009 in the Humana Health System in Chicago, Illinois, and Fort Lauderdale, Florida. Our primary end point was hard ASCVD, defined as cardiovascular death, myocardial infarction, and stroke. A total of 3,635 adults who were not on lipid-lowering therapy at baseline were followed for a maximum of 4.6 years. The mean age was 68.6 years; 2000 (55%) participants were women and 935 patients reported being of non-white race (26%). Although 74 ASCVD events were observed over a median follow-up of 2.7 years, 198 events were predicted by the PCEs. The observed event rate was 7.9 per 1,000 participant-years (95% confidence interval [CI] 6.1 to 9.8), whereas the predicted rate by the PCEs was 21 per 1,000 participant-years (95% CI 20.7 to 21.8). This represents an overestimation of 167% (Hosmer-Lemeshow chi-square = 173; p <0.001). With regard to discrimination, the C-statistic of the PCEs was 0.65 (CI 0.58 to 0.71). In an analysis restricted to 3,080 participants without diabetes mellitus and with low-density lipoprotein cholesterol between 70 and 189 mg/dl, the PCEs similarly overestimated risk by 181% (152 predicted events vs 54 observed events; p <0.001). The PCEs substantially overestimate ASCVD risk in this middle-aged adult insured population. Refinement of existing risk prediction functions may be warranted.

摘要

大多数指南建议进行基线风险评估,以指导动脉粥样硬化性心血管疾病(ASCVD)的预防策略。美国心脏协会/美国心脏病学会合并队列方程(PCEs)是评估基线风险的一种工具;然而,该工具的准确性受到了质疑。我们旨在研究PCEs在BioImage研究中的校准和区分能力,这是一项当代多民族无症状成年人队列研究,于2008年至2009年在伊利诺伊州芝加哥和佛罗里达州劳德代尔堡的Humana医疗系统中招募。我们的主要终点是严重ASCVD,定义为心血管死亡、心肌梗死和中风。共有3635名基线时未接受降脂治疗的成年人接受了最长4.6年的随访。平均年龄为68.6岁;2000名(55%)参与者为女性,935名患者报告为非白人种族(26%)。尽管在中位随访2.7年期间观察到74例ASCVD事件,但PCEs预测了198例事件。观察到的事件发生率为每1000参与者年7.9例(95%置信区间[CI]6.1至9.8),而PCEs预测的发生率为每1000参与者年21例(95%CI 20.7至21.8)。这代表高估了167%(Hosmer-Lemeshow卡方=173;p<0.001)。关于区分能力,PCEs的C统计量为0.65(CI 0.58至0.71)。在一项仅限于3080名无糖尿病且低密度脂蛋白胆固醇在70至189mg/dl之间的参与者的分析中,PCEs同样高估了风险181%(预测事件152例,观察到事件54例;p<0.001)。在这个中年成人参保人群中,PCEs大幅高估了ASCVD风险。可能有必要完善现有的风险预测函数。

相似文献

1
Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort.当代前瞻性队列中用于预测心血管风险的合并队列方程的评估
Am J Cardiol. 2017 Mar 15;119(6):881-885. doi: 10.1016/j.amjcard.2016.11.042. Epub 2016 Dec 18.
2
Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.比较 ACC/AHA 指南、成人治疗专家组 III 指南和欧洲心脏病学会指南在欧洲队列中用于心血管疾病预防的应用。
JAMA. 2014 Apr 9;311(14):1416-23. doi: 10.1001/jama.2014.2632.
3
Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.当代大型多民族人群中动脉粥样硬化性心血管疾病风险方程的准确性
J Am Coll Cardiol. 2016 May 10;67(18):2118-2130. doi: 10.1016/j.jacc.2016.02.055.
4
Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.新西兰 40 万例初级保健患者的心血管疾病风险预测方程:一项推导和验证研究。
Lancet. 2018 May 12;391(10133):1897-1907. doi: 10.1016/S0140-6736(18)30664-0. Epub 2018 May 4.
5
The new pooled cohort equations risk calculator.新的合并队列方程风险计算器。
Can J Cardiol. 2015 May;31(5):613-9. doi: 10.1016/j.cjca.2015.02.001. Epub 2015 Feb 4.
6
Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative.在女性健康倡议的多民族队列中评估用于心血管风险预测的合并队列风险方程。
JAMA Intern Med. 2018 Sep 1;178(9):1231-1240. doi: 10.1001/jamainternmed.2018.2875.
7
Cardiovascular Risk Associated With Social Determinants of Health at Individual and Area Levels.心血管疾病风险与个体和地区健康社会决定因素的关联。
JAMA Netw Open. 2024 Apr 1;7(4):e248584. doi: 10.1001/jamanetworkopen.2024.8584.
8
An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.现代多民族队列中多种心血管风险评分的校准与鉴别分析。
Ann Intern Med. 2015 Feb 17;162(4):266-75. doi: 10.7326/M14-1281.
9
Implications of the US cholesterol guidelines on eligibility for statin therapy in the community: comparison of observed and predicted risks in the Framingham Heart Study Offspring Cohort.美国胆固醇指南对社区他汀类药物治疗资格的影响:弗明汉心脏研究后代队列中观察到的风险与预测风险的比较
J Am Heart Assoc. 2015 Apr 17;4(4):e001888. doi: 10.1161/JAHA.115.001888.
10
A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.对 2013 年 ACC/AHA pooled cohort 风险评估工具用于动脉粥样硬化性心血管疾病的系统检查。
J Am Coll Cardiol. 2014 Sep 9;64(10):959-68. doi: 10.1016/j.jacc.2014.06.1186.

引用本文的文献

1
Performance of the American Heart Association PREVENT Cardiovascular Risk Equations in Older Adults.美国心脏协会预防心血管风险方程在老年人中的表现。
Circ Cardiovasc Qual Outcomes. 2025 Jun;18(6):e011719. doi: 10.1161/CIRCOUTCOMES.124.011719. Epub 2025 Apr 28.
2
Chronic low-grade inflammation in patients with systemic sclerosis is associated with increased risk for arteriosclerotic cardiovascular disease.系统性硬化症患者的慢性低度炎症与动脉粥样硬化性心血管疾病风险增加相关。
Front Med (Lausanne). 2024 Nov 5;11:1446268. doi: 10.3389/fmed.2024.1446268. eCollection 2024.
3
Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?
精准医学与心血管预防及人群健康:难以跨越的桥梁?
Circulation. 2024 Nov 19;150(21):1720-1731. doi: 10.1161/CIRCULATIONAHA.124.070081. Epub 2024 Nov 18.
4
Impact of Social Vulnerability and Demographics on Ischemic Heart Disease Mortality in the United States.社会脆弱性和人口统计学对美国缺血性心脏病死亡率的影响。
JACC Adv. 2023 Aug 24;2(7):100577. doi: 10.1016/j.jacadv.2023.100577. eCollection 2023 Sep.
5
Integrating Indices of Genetic Risk for Cardiovascular Disease.整合心血管疾病遗传风险指标
JACC Adv. 2023 Aug 24;2(7):100568. doi: 10.1016/j.jacadv.2023.100568. eCollection 2023 Sep.
6
Machine learning models for predicting blood pressure phenotypes by combining multiple polygenic risk scores.基于多种多基因风险评分预测血压表型的机器学习模型。
Sci Rep. 2024 May 30;14(1):12436. doi: 10.1038/s41598-024-62945-9.
7
Machine learning models for blood pressure phenotypes combining multiple polygenic risk scores.结合多个多基因风险评分的血压表型机器学习模型。
medRxiv. 2023 Dec 14:2023.12.13.23299909. doi: 10.1101/2023.12.13.23299909.
8
Evidence supporting the choice of a new cardiovascular risk equation for Australia.支持为澳大利亚选择新心血管风险方程的证据。
Med J Aust. 2023 Aug 21;219(4):173-186. doi: 10.5694/mja2.52052. Epub 2023 Jul 26.
9
Performance of the pooled cohort equations in cancer survivors: the Atherosclerosis Risk in Communities study.癌症幸存者 pooled cohort 方程的表现:社区动脉粥样硬化风险研究。
J Cancer Surviv. 2024 Feb;18(1):124-134. doi: 10.1007/s11764-023-01379-0. Epub 2023 May 4.
10
Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine.个性化医疗时代的心血管疾病风险预测模型与评分
J Pers Med. 2022 Jul 20;12(7):1180. doi: 10.3390/jpm12071180.